A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With a History of Inadequate Response to Oral Preventative Medications
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With a History of Inadequate Response to…
Read the full articleYou might also wanna read
WHO Regional Director for Africa’s visit to South Africa
iarc.who.int·1h ago
Long COVID Spending Falls Sharply After Three Months
emjreviews.com·3h ago
Walking Near Traffic May Aggravate COPD Symptoms
emjreviews.com·4h ago
King's College London study identifies novel mechanism of brain cell death in Alzheimer's disease
sciencealert.com·5h ago
Dementia rates among elderly Americans are declining, research shows
economist.com·6h ago
How extreme heat impairs cognitive function and mental health: What researchers know so far
technologyreview.com·6h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.